Cargando…
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
Autores principales: | Zu, Shulong, Luo, Dan, Li, Lili, Ye, Qing, Li, Rui-Ting, Wang, Yanan, Gao, Meiling, Yang, Heng, Deng, Yong-Qiang, Cheng, Genhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688909/ https://www.ncbi.nlm.nih.gov/pubmed/34934049 http://dx.doi.org/10.1038/s41392-021-00853-4 |
Ejemplares similares
-
Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome
por: Dhaliwal, Lakhbir Kaur, et al.
Publicado: (2011) -
ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
por: Li, Lili, et al.
Publicado: (2021) -
Tamoxifen is Better than Low-Dose Clomiphene or Gonadotropins in Women with Thin Endometrium (<7 mm) after Clomiphene in Intrauterine Insemination Cycles: A Prospective Study
por: Sharma, Sunita, et al.
Publicado: (2018) -
Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation
por: Seyedoshohadaei, Fariba, et al.
Publicado: (2012) -
Comparison of Letrozole Versus Tamoxifen Effects in Clomiphen Citrate Resistant Women with Polycystic Ovarian Syndrome
por: EL-Gharib, Mohamed Nabih, et al.
Publicado: (2015)